Status:
UNKNOWN
G-CSF for the Prevention of Febrile Neutropenia in Gynecologic Cancer Patients
Lead Sponsor:
Lei Li
Conditions:
Gynecologic Cancer
Myelosuppression Adult
Eligibility:
FEMALE
18+ years
Phase:
PHASE4
Brief Summary
This study aims to analyze the effects of long-acting granulocyte colony stimulating factor (G-CSF) on the prevention febrile neutropenia (FN) in gynecologic cancer patients. Patients all accepted pla...
Eligibility Criteria
Inclusion
- Confirmed primary gynecologic cancer
- Good performance status
- Aged 18 years or older
- Signed an approved informed consents
- No immunosuppressive disease
Exclusion
- Not meeting all of the inclusion criteria
Key Trial Info
Start Date :
January 3 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
January 1 2020
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT03793205
Start Date
January 3 2019
End Date
January 1 2020
Last Update
January 7 2019
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Lei Li
Beijing, Beijing Municipality, China, 100730